156 related articles for article (PubMed ID: 27087510)
1. Characterizing urinary hCGβcf patterns during pregnancy.
Nerenz RD; Yarbrough ML; Stenman UH; Gronowski AM
Clin Biochem; 2016 Jul; 49(10-11):777-81. PubMed ID: 27087510
[TBL] [Abstract][Full Text] [Related]
2. Estimating the hCGβcf in urine during pregnancy.
Nerenz RD; Butch AW; Woldemariam GA; Yarbrough ML; Grenache DG; Gronowski AM
Clin Biochem; 2016 Feb; 49(3):282-6. PubMed ID: 26541857
[TBL] [Abstract][Full Text] [Related]
3. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
Milhorn D; Korpi-Steiner N
Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a semi-quantitative pregnancy device for susceptibility to interference caused by hCGβcf.
Nerenz RD; Butch AW; Ashby L; Woldemariam GA; Gronowski AM
Clin Biochem; 2015 Aug; 48(12):815-7. PubMed ID: 25916816
[TBL] [Abstract][Full Text] [Related]
5. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices.
Nerenz RD; Song H; Gronowski AM
Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559
[TBL] [Abstract][Full Text] [Related]
6. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays.
Grenache DG; Greene DN; Dighe AS; Fantz CR; Hoefner D; McCudden C; Sokoll L; Wiley CL; Gronowski AM
Clin Chem; 2010 Dec; 56(12):1839-44. PubMed ID: 20930131
[TBL] [Abstract][Full Text] [Related]
7. Urinary human chorionic gonadotropin isoform concentrations in doping control samples.
Butch AW; Woldemariam GA
Drug Test Anal; 2016 Nov; 8(11-12):1147-1151. PubMed ID: 27594536
[TBL] [Abstract][Full Text] [Related]
8. Cross-reaction with luteinizing hormone beta-core is responsible for the age-dependent increase of immunoreactive beta-core fragment of human chorionic gonadotropin in women with nonmalignant conditions.
Iles RK; Javid MK; Gunn LK; Chard T
Clin Chem; 1999 Apr; 45(4):532-8. PubMed ID: 10102914
[TBL] [Abstract][Full Text] [Related]
9. Beta-core fragment is a major form of immunoreactive urinary chorionic gonadotropin in human pregnancy.
Kato Y; Braunstein GD
J Clin Endocrinol Metab; 1988 Jun; 66(6):1197-201. PubMed ID: 2453528
[TBL] [Abstract][Full Text] [Related]
10. hCGbeta core fragment is a metabolite of hCG: evidence from infusion of recombinant hCG.
Norman RJ; Buchholz MM; Somogyi AA; Amato F
J Endocrinol; 2000 Mar; 164(3):299-305. PubMed ID: 10694369
[TBL] [Abstract][Full Text] [Related]
11. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment.
Gronowski AM; Cervinski M; Stenman UH; Woodworth A; Ashby L; Scott MG
Clin Chem; 2009 Jul; 55(7):1389-94. PubMed ID: 19395437
[TBL] [Abstract][Full Text] [Related]
12. Persistently elevated serum concentrations of human chorionic gonadotropin (hCG).
Collazo Abal C; Fernández Marcos MC; Casado Rey P; Vázquez Caamaño MP; Alfthan H; Koistinen H; Stenman UH
Clin Chem Lab Med; 2023 Oct; 61(11):2028-2032. PubMed ID: 37279342
[TBL] [Abstract][Full Text] [Related]
13. The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives.
Berger P; Sturgeon C; Bidart JM; Paus E; Gerth R; Niang M; Bristow A; Birken S; Stenman UH
Tumour Biol; 2002; 23(1):1-38. PubMed ID: 11893904
[TBL] [Abstract][Full Text] [Related]
14. False-negative results from point-of-care qualitative human chorionic gonadotropin (hCG) devices caused by excess hCGbeta core fragment vary with device lot number.
Gronowski AM; Powers M; Stenman UH; Ashby L; Scott MG
Clin Chem; 2009 Oct; 55(10):1885-6. PubMed ID: 19679628
[No Abstract] [Full Text] [Related]
15. Determination of human chorionic gonadotropin.
Stenman UH; Alfthan H
Best Pract Res Clin Endocrinol Metab; 2013 Dec; 27(6):783-93. PubMed ID: 24275190
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care and over-the-counter qualitative human chorionic gonadotropin (hCG) devices remain susceptible to false-negative results caused by excess hCG β core fragment.
Nerenz RD; Gronowski AM
Clin Chem; 2013 Nov; 59(11):1672-4. PubMed ID: 23985957
[No Abstract] [Full Text] [Related]
17. Human chorionic gonadotropin in pregnancy diagnostics.
Montagnana M; Trenti T; Aloe R; Cervellin G; Lippi G
Clin Chim Acta; 2011 Aug; 412(17-18):1515-20. PubMed ID: 21635878
[TBL] [Abstract][Full Text] [Related]
18. Determination of the glycoforms of human chorionic gonadotropin beta-core fragment by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Jacoby ES; Kicman AT; Laidler P; Iles RK
Clin Chem; 2000 Nov; 46(11):1796-803. PubMed ID: 11067815
[TBL] [Abstract][Full Text] [Related]
19. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
Spencer K; Aitken DA; Macri JN; Buchanan PD
Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
[TBL] [Abstract][Full Text] [Related]
20. Immunoextraction-tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free β-subunit, and β-subunit core fragment in urine.
Woldemariam GA; Butch AW
Clin Chem; 2014 Aug; 60(8):1089-97. PubMed ID: 24899693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
